ELVN · Enliven Therapeutics, Inc.
Market Cap
$4.24B
Shares
73.27M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-11 | ELVN-001: June 2026 Clinical Data Update | Event |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-27 | TD Cowen Annual Oncology Innovation Summit: Insights for ASCO & EHA | Event |
| 2026-03-03 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2025-06-13 | ELVN-001 Clinical Data Update - EHA Edition | Event |
| 2024-04-11 | ELVN-001 Initial Proof of Concept Data and the Evolving CML Landscape | Event |
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
196 filings
193 filers
Visit website
Investor relations